Status:
UNKNOWN
Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Leukemia, Lymphoblastic
Eligibility:
All Genders
1-15 years
Brief Summary
Background: Mexico City has one of the highest incidences and mortality rates of acute lymphoblastic leukemia (ALL) in the world and a high frequency of early relapses (17%) and early mortality (15%)....
Detailed Description
Data collection Information regarding sex, age at diagnosis, place of residence, white blood cell (WBC) count, immunophenotype (B or T lineage), weight and height (length when appropriate) at diagnosi...
Eligibility Criteria
Inclusion
- Patients under 15 years of age
- Newly diagnosed with acute lymphoblastic leukemia
- Diagnosis confirmation by bone marrow aspiration and immunophenotype
- Attended in the participating Hospitals.
Exclusion
- \- Patients with Down Syndrome (for being a population with different disease behavior and cytogenetic alterations than patients without this genetic condition)
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04271215
Start Date
January 1 2010
End Date
December 31 2022
Last Update
July 20 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Médico Nacional Hospital General La Raza, IMSS
Mexico City, Mexico, 02990
2
Hospital General Regional Num 1 Carlos McGregor Sánchez Navarro, IMSS
Mexico City, Mexico, 03103
3
Hospital de Pediatria "Dr. Silvestre Frenk Freund" CMN Siglo XXI, IMSS
Mexico City, Mexico, 06720